Citi upgraded Acceleron Pharma (NASDAQ: XLRN) from Neutral to Buy with a price target of $36.00.Analyst Dr. Robyn Karnauskas comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE